SC 13G/A: Kiniksa Pharmaceuticals, Ltd.

AI Summary

SC 13G/A filing by Kiniksa Pharmaceuticals, Ltd..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.000273235 — uer) Class A Common Shares, par value $0.000273235 per share (Title of Class of Securitie

Filing Documents

• p24-0563sc13ga.htm (SC 13G/A) — 56KB
• 0000902664-24-001735.txt ( ) — 58KB

(a)

Item 1(a). NAME OF ISSUER: The name of the issuer is Kiniksa Pharmaceuticals, Ltd. (the " Company ").

(b)

Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: The Company's principal executive office is located at Clarendon House, 2 Church Street, Hamilton HM11, Bermuda.

(a)

Item 2(a). NAME OF PERSON FILING: This statement is filed by: (i) HHLR Advisors, Ltd., an exempted Cayman Islands company (" HHLR ") and (ii) Hillhouse Investment Management, Ltd., an exempted Cayman Islands company (" HIM "). The foregoing persons are hereinafter sometimes each referred to as a " Reporting Person " and collectively referred to as the " Reporting Persons ." HHLR acts as the sole investment manager of HHLR Fund, L.P. (" HHLR Fund "). HHLR is hereby deemed to be the beneficial owner of, and to control the voting and investment power of, the Class A Common Shares (as defined in Item 2(d) below) held by HHLR Fund. HIM acts as the sole management company of Hillhouse Fund III, L.P. (" Fund III "). HH RSV-XVII Holdings Limited (" HH RSV XVII ") is wholly owned by Fund III. HIM is hereby deemed to be the beneficial owner of, and to control the voting and investment power of, the Class A Common Shares issuable upon conversion of the Issuer's Class A1 Common Shares held by HH RSV XVII. HHLR and HIM are under common control and share certain policies, personnel and resources. Accordingly, each of HHLR and HIM reports on this Schedule 13G/A that it has shared voting and dispositive power of the Class A Common Shares beneficially owned by each of HHLR and HIM.

(b)

Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: The address of the business office of each of the Reporting Persons is Office #122, Windward 3 Building, Regatta Office Park, West Bay Road, Grand Cayman, Cayman Islands, KY1-9006.

(c)

Item 2(c). CITIZENSHIP: Cayman Islands

(d)

Item 2(d). TITLE OF CLASS OF SECURITIES: Class A Common Shares, par value $0.000273235 per share (the " Class A Common Shares "). CUSIP No. G5269C101 13G/A Page 5 of 7 Pages

(e)

Item 2(e). CUSIP NUMBER: G5269C101 Item 3. IF THIS STATEMENT IS FILED PURSUANT TO Rules 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) ¨ Broker or dealer registered under Section 15 of the Act; (b) ¨ Bank as defined in Section 3(a)(6) of the Act; (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act; (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940; (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) ¨ A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) ¨ A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. OWNERSHIP: The percentage and beneficial ownership information set forth in this Schedule 13G/A was calculated based upon an aggregate of 35,409,710 Class A Common Shares outstanding as of October 27, 2023, as reported in the Company's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023, filed with the Securities and Exchange Commission on November 2, 2023, and assumes the conversion of the Class A1 Shares held by HH RSV XVII, subject to the Blocker. The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each of the Reporting Persons (and the footnotes thereto) and is incorporated herein by reference. CUSIP No. G5269C101 13G/A Page 6 of 7 Page

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. DATE: February 14, 2024 HHLR Advisors, LTD. /s/ Audrey Woon Name:Audrey Woon Title:Chief Compliance Officer Hillhouse Investment Management, Ltd. /s/ Audrey Woon Name:Audrey Woon Title:Chief Compliance Officer